{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Combination+Group&page=23", "query": { "intervention": "Combination Group", "page": 23 }, "page_size": 10 }, "pagination": { "page": 23, "page_size": 10, "total_count": 2795, "total_pages": 280, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Combination+Group&page=24&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Combination+Group&page=22&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T00:28:10.190Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05254002", "title": "A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is Compared to Each Treatment Alone in Adult Participants With Long-term Kidney Disease (Chronic Kidney Disease) and Type 2 Diabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Type 2 Diabetes Mellitus", "Chronic Kidney Disease" ], "interventions": [ { "name": "Finerenone (BAY94-8862 ) 10 mg", "type": "DRUG" }, { "name": "Empagliflozin", "type": "DRUG" }, { "name": "Empagliflozin Placebo", "type": "DRUG" }, { "name": "Finerenone (BAY94-8862 ) 20 mg", "type": "DRUG" }, { "name": "Finerenone Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1664, "start_date": "2022-06-23", "completion_date": "2025-03-17", "has_results": true, "last_update_posted_date": "2026-07-13", "last_synced_at": "2026-11-15T00:28:10.190Z", "location_count": 46, "location_summary": "Surprise, Arizona • Los Angeles, California • Northridge, California + 36 more", "locations": [ { "city": "Surprise", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Northridge", "state": "California" }, { "city": "Sylmar", "state": "California" }, { "city": "Vallejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05254002" }, { "nct_id": "NCT07588984", "title": "GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study", "overall_status": "NOT_YET_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Obesity & Overweight", "Weight Loss", "Preventative Health", "Body Weight", "Cardiovascular Disease Risk Factor" ], "interventions": [ { "name": "Noom Weight", "type": "BEHAVIORAL" }, { "name": "Free Tier", "type": "BEHAVIORAL" }, { "name": "Education-only control", "type": "BEHAVIORAL" }, { "name": "Semaglutide", "type": "DRUG" }, { "name": "Tirzepatide", "type": "DRUG" }, { "name": "Microdose semaglutide", "type": "DRUG" }, { "name": "Microdose tirzepatide", "type": "DRUG" } ], "intervention_types": [ "BEHAVIORAL", "DRUG" ], "sponsor": "Noom Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 2310, "start_date": "2026-04-30", "completion_date": "2029-05", "has_results": false, "last_update_posted_date": "2026-05-15", "last_synced_at": "2026-11-15T00:28:10.190Z", "location_count": 1, "location_summary": "Princeton, New Jersey", "locations": [ { "city": "Princeton", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07588984" }, { "nct_id": "NCT02661815", "title": "A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Ovarian Cancer", "Fallopian Tube Cancer", "Primary Peritoneal Carcinoma" ], "interventions": [ { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Ricolinostat", "type": "DRUG" }, { "name": "Bevacizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dana-Farber Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 6, "start_date": "2016-06-15", "completion_date": "2017-07-28", "has_results": true, "last_update_posted_date": "2019-11-08", "last_synced_at": "2026-11-15T00:28:10.190Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02661815" }, { "nct_id": "NCT01248208", "title": "FluMist in Egg Allergic Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Egg Allergy", "Eligible for Vaccination Against Influenza" ], "interventions": [ { "name": "FluMist intranasal influenza vaccine", "type": "BIOLOGICAL" }, { "name": "Intramuscular influenza injection (\"flu shot\")", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Walter Reed Army Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Months", "maximum_age": null, "sex": "ALL", "summary": "6 Months and older" }, "enrollment_count": 17, "start_date": "2010-09", "completion_date": "2012-10", "has_results": false, "last_update_posted_date": "2018-10-03", "last_synced_at": "2026-11-15T00:28:10.190Z", "location_count": 1, "location_summary": "Washington D.C., District of Columbia", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01248208" }, { "nct_id": "NCT00680017", "title": "30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dyslipidemia", "Kidney Disease" ], "interventions": [ { "name": "ABT-335 plus rosuvastatin", "type": "DRUG" }, { "name": "Rosuvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 280, "start_date": "2008-06", "completion_date": "2011-04", "has_results": true, "last_update_posted_date": "2012-10-03", "last_synced_at": "2026-11-15T00:28:10.190Z", "location_count": 102, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Madison, Alabama + 93 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Madison", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Chula Vista", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00680017" }, { "nct_id": "NCT06397768", "title": "Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "RSV Immunization" ], "interventions": [ { "name": "RSVt vaccine", "type": "BIOLOGICAL" }, { "name": "Diphtheria, tetanus, pertussis, poliomyelitis , Haemophilus influenzae type b, and hepatitis B vaccine", "type": "BIOLOGICAL" }, { "name": "Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis B vaccine", "type": "BIOLOGICAL" }, { "name": "Streptococcus pneumoniae vaccine", "type": "BIOLOGICAL" }, { "name": "Rotavirus vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, mumps, and rubella vaccine", "type": "BIOLOGICAL" }, { "name": "Varicella virus vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "12 Months", "sex": "ALL", "summary": "6 Months to 12 Months" }, "enrollment_count": 2226, "start_date": "2024-05-13", "completion_date": "2025-09-18", "has_results": false, "last_update_posted_date": "2026-10-05", "last_synced_at": "2026-11-15T00:28:10.190Z", "location_count": 66, "location_summary": "Birmingham, Alabama • Grand Bay, Alabama • Mobile, Alabama + 55 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Grand Bay", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Bell Gardens", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06397768" }, { "nct_id": "NCT00463385", "title": "A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Myelofibrosis With Myeloid Metaplasia", "Myeloid Metaplasia", "Myelofibrosis" ], "interventions": [ { "name": "Pomalidomide", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Placebo to pomalidomide", "type": "DRUG" }, { "name": "Placebo to prednisone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 88, "start_date": "2007-04-01", "completion_date": "2013-12-31", "has_results": true, "last_update_posted_date": "2019-11-20", "last_synced_at": "2026-11-15T00:28:10.190Z", "location_count": 6, "location_summary": "Los Angeles, California • Rochester, Minnesota • New York, New York + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00463385" }, { "nct_id": "NCT02317640", "title": "TRT in Combination With Electrical Stimulation and Standing: Effect on Muscle and Bone in Spinal Cord Injured Males", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Spinal Cord Injury" ], "interventions": [ { "name": "Testosterone Gel applied by a pump", "type": "DRUG" }, { "name": "Stand Training", "type": "OTHER" }, { "name": "Electrical Stimulation", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "OTHER", "DEVICE" ], "sponsor": "Kessler Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "58 Years", "sex": "MALE", "summary": "18 Years to 58 Years · Male only" }, "enrollment_count": 56, "start_date": "2017-03-15", "completion_date": "2022-10", "has_results": false, "last_update_posted_date": "2017-08-22", "last_synced_at": "2026-11-15T00:28:10.190Z", "location_count": 1, "location_summary": "West Orange, New Jersey", "locations": [ { "city": "West Orange", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT02317640" }, { "nct_id": "NCT01280591", "title": "Evaluate Analgesic/Sedative Efficacy of Naproxen Sodium and Diphenhydramine in Patients With Postsurgical Dental Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pain, Postoperative" ], "interventions": [ { "name": "Naproxen sodium 440 mg / DPH 50 mg (BAY98-7111)", "type": "DRUG" }, { "name": "Naproxen sodium 220 mg / DPH 50 mg (BAY98-7111)", "type": "DRUG" }, { "name": "Naproxen sodium 440 mg (BAYH6689)", "type": "DRUG" }, { "name": "DPH 50 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "12 Years to 45 Years" }, "enrollment_count": 712, "start_date": "2010-10", "completion_date": "2011-02", "has_results": true, "last_update_posted_date": "2015-06-08", "last_synced_at": "2026-11-15T00:28:10.190Z", "location_count": 2, "location_summary": "Austin, Texas • Salt Lake City, Utah", "locations": [ { "city": "Austin", "state": "Texas" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT01280591" }, { "nct_id": "NCT03576274", "title": "Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cancer-related Problem/Condition", "Exercise", "Acupressure" ], "interventions": [ { "name": "Technology Enhanced Home Exercise (TEHE)", "type": "BEHAVIORAL" }, { "name": "Auricular Point Acupressure (APA)", "type": "BEHAVIORAL" }, { "name": "Mindfulness body scan (MBI)", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": null, "sex": "ALL", "summary": "21 Years and older" }, "enrollment_count": 110, "start_date": "2019-10-10", "completion_date": "2024-09-15", "has_results": true, "last_update_posted_date": "2025-10-10", "last_synced_at": "2026-11-15T00:28:10.190Z", "location_count": 1, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03576274" } ] }